Zobrazeno 1 - 10
of 465
pro vyhledávání: '"Artemisinin Combination Therapy"'
Autor:
Paula Tesine, Sze-Ann Woon, Moses Laman, Gumul Yadi, Phantica Yambo, Bernadine Kasian, Lina Lorry, Leanne J. Robinson, Sam Salman, Kevin T. Batty, William Pomat, Laurens Manning, Wendy A. Davis, Timothy M.E. Davis, Brioni R. Moore
Publikováno v:
International Journal of Infectious Diseases, Vol 149, Iss , Pp 107258- (2024)
Objectives: Although the incidence of malaria is increased in women in endemic areas after delivery compared to non-pregnant women, no studies have assessed the benefit of presumptive antimalarial treatment given postpartum. Methods: A randomised con
Externí odkaz:
https://doaj.org/article/3fbd30a624044f5ab2ff4ace3a2bae39
Autor:
Albert A. Gnondjui, Offianan A. Toure, Berenger A. Ako, Tossea S. Koui, Stanislas E. Assohoun, Eric A. Gbessi, Landry T. N’Guessan, Karim Tuo, Sylvain Beourou, Serge-Brice Assi, Francis A. Yapo, Ibrahima Sanogo, Ronan Jambou
Publikováno v:
Malaria Journal, Vol 23, Iss 1, Pp 1-13 (2024)
Abstract Background Decreased efficacy of artemisinin-based combination therapy (ACT) for Plasmodium falciparum malaria has been previously reported in patients with sickle cell disease (SCD). The main purpose of this study was to investigate the in
Externí odkaz:
https://doaj.org/article/75f1c88a89f64bb7afe90c80c992ebd0
Autor:
Swati Sinha, Supriya Sharma, Kuldeep Singh, Deendayal Swarnkar, Naseem Ahmed, Priyanka Rajput, Bina Srivastava, Anup R Anvikar
Publikováno v:
Journal of Vector Borne Diseases, Vol 61, Iss 1, Pp 81-89 (2024)
Background & objectives: Malaria due to Plasmodium falciparum (Pf) remains a major public threat in India. Artemisinin-based combination therapy (ACT) has been the country’s first-line drug for uncomplicated Pf malaria. In 2013-2014, Artesunate plu
Externí odkaz:
https://doaj.org/article/8a1a949f679f4600a3175505f0ab983e
Autor:
Sylvatrie-Danne Dinzouna-Boutamba, Berthe Amélie Iroungou, Falone Larissa Akombi, Lauriane Yacka-Mouele, Zin Moon, Ja Moon Aung, Sanghyun Lee, Dong-Il Chung, Yeonchul Hong, Youn-Kyoung Goo
Publikováno v:
Malaria Journal, Vol 22, Iss 1, Pp 1-9 (2023)
Abstract Background Gabon is a malaria-threatened country with a stable and hyperendemic transmission of Plasmodium falciparum monoinfection. Malaria drug resistance is widely spread in many endemic countries around the world, including Gabon. The mo
Externí odkaz:
https://doaj.org/article/d93ff032821340b3843c31518d452973
Autor:
Anton L. V. Avanceña, Angie Miller, Neide Canana, Janeth Dula, Abuchahama Saifodine, Baltazar Cadrinho, Elisa M. Maffioli
Publikováno v:
Malaria Journal, Vol 21, Iss 1, Pp 1-10 (2022)
Abstract Background The entire population of Mozambique is at risk for malaria, which remains one of the leading causes of death. The 2017–2022 National Malaria Strategic Plan focuses on reducing malaria morbidity and mortality in high- and low-tra
Externí odkaz:
https://doaj.org/article/34861b95c2fb4317b8b3e53518d4d8fb
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Pedro Berzosa, Irene Molina de la Fuente, Thuy-Huong Ta-Tang, Vicenta González, Luz García, Ana Rodríguez-Galet, Ramón Díaz-Regañón, Rosario Galán, Laura Cerrada-Gálvez, Policarpo Ncogo, Matilde Riloha, Agustin Benito
Publikováno v:
Malaria Journal, Vol 20, Iss 1, Pp 1-17 (2021)
Abstract Background Malaria is one of the deadliest diseases in the world, particularly in Africa. As such, resistance to anti-malarial drugs is one of the most important problems in terms of global malaria control. This study assesses the evolution
Externí odkaz:
https://doaj.org/article/5eb26db402a44308b1e72556761607cb
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Open Health, Vol 4, Iss 1, Pp 167-61 (2023)
Human cytochrome P450 2B6 (CYP2B6) is fortified with the biotransformation of the antimalarial, artemisinin combination therapy (ACT). Owing to emerging reports of Plasmodium species resistance to ACT in other climes, CYP2B6*6 genotype significantly
Externí odkaz:
https://doaj.org/article/335043b280854e4eb71d7c7cd4d1f2e3